Results
1 -
6 of
6Development of novel antibacterial drugs to combat multiple resistant organisms, Langenbeck's Archives of Surgery Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin, Annals of Clinical Microbiology and Antimicrobials Molecular docking studies on thirteen fluoroquinolines with human topoisomerase II a and b, In Silico Pharmacology Finafloxacin: First Global Approval, Drugs Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D..
Finafloxacin, Pharmaceutical Substances [Online], Thieme: Stuttgart, (2016).